A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is
The time to ANC Ͼ500 ranged from 8 to 19 days with a median of 10 days. The median length of stay was 21 days. Three patients experienced early treatment-related mortality. With median follow up of 21 months, 45 patients have relapsed. The five year disease free survival (DFS) is 26% and overall survival (OS) is 58%. Thirty-nine patients (44%) remain alive and disease free. There was no difference in DFS (P ϭ .82)or OS (p ϭ .55) between those patients who received 4 cycles of VAD compared todoi:10.1016/j.bbmt.2003.12.092 fatcat:xl5fdoxg2ndu7pqiqinl2sih3m